Advocacy in Action

Endocrine Society Leads Advocacy to Pass INSULIN ACT

On November 12, the Endocrine Society sent two coalition letters signed by 16 patient and provider organizations calling for the immediate passage of the INSULIN Act. The letters, which were sent to the White House and congressional leadership, urge Congress and the White House to work together to pass the INSULIN Act before the end of the year. This bipartisan legislation would expand the $35 insulin co-pay cap, currently available to Medicare beneficiaries, to people on private insurance. The Society is making a final push to pass this important legislation during the lame duck session. The letter to Congress can be found here and the letter to the White House is available here on our website.

CMS Releases Medicare Physician Fee Schedule Final Rule

On November 5, the Centers for Medicare and Medicaid Services (CMS) released the Medicare Physician Fee Schedule (MPFS) final rule for Calendar Year 2027. The Society has developed a summary of the policies in the rule that will affect endocrinologists on our website. We are continuing to review the final rule and will provide a more detailed analysis in the coming days. CMS estimates that the rule will have a net impact of +1% in total Medicare payments for the endocrinology specialty. The final rule also includes a provision that will increase payments for Final Needle Aspiration (FNA), a procedure performed by endocrinologists, by 20 percent. The final rule includes a provision that eliminates the G2211 complex care add-on code and replaces it with a modifier. The Society urged CMS not to finalize this proposal because of the impact it would have on work RVUs for physicians. We are disappointed by this decision but will continue to advocate for CMS to address this issue. The final rule will take effect on January 1, 2027. The Society commented on the proposed rule in September, and we worked closely with the Clinical Affairs Core Committee to develop our comments. You can read our comments here on our website.

AMA Passes Endocrine Society Resolution Advocating for Women’s Health Research

This week, Endocrine Society members attended the American Medical Association (AMA) House of Delegates meeting and successfully advocated for issues important to endocrinology, including women’s health research. The AMA House of Delegates, which is the legislative and policy-making body of the AMA, meets twice a year to consider changes to AMA policy. During the meeting, the Society supported resolutions focused on women’s health, coverage of embryonic monogenic disorder screening, and opposition to mandatory testosterone testing. The House of Delegates also passed the Endocrine Society’s resolution to support efforts to close the women’s health gap in research. The AMA committed to addressing the urgent need for women's health research and robust and sustained funding across federal agencies. The Endocrine Society and American College of Obstetricians & Gynecologists (ACOG) introduced the resolution. A special thanks to our delegates, Amanda Bell and Barbara Onumah for attending the AMA meeting and representing the Society and successfully advocating for issues important to endocrinologists.

Join our Campaign to Protect NIH Research and Block OMB Rule

The Endocrine Society is fighting to protect NIH research. The proposed Office of Management and Budget (OMB) rule, “Regulation for Federal Financial Assistance” will jeopardize the future of merit-based research funding. Congress has only been able to pass a short-term continuing resolution (CR) to fund the federal government through December 11.

We are calling on Congress to urge the Administration to withdraw the proposed rule and prevent the enactment of any policies that undermine a federal grant system grounded in scientific merit, transparency, and stability. It is imperative that all Senators and Representatives hear from their constituents about the importance of funding NIH. Many congressional offices are not aware how disruptions to grant funding threaten the work done in their states or districts. Join our campaign today!